LeaderPortfolio
family
Sergio Stevanato & family
Rank #977
ITALYHealthcareMedical packaging

Sergio Stevanato & family

Net Worth
$4.305B
-4.66% (24h)
Sergio Stevanato, born in Venice, Italy, in 1943, is the chairman emeritus of the Stevanato Group, a leading medical packaging firm. With a law degree from the University of Ferrara, Stevanato transformed his father's glass manufacturing company, founded in 1949, into a global leader in medical packaging and drug delivery solutions. The Stevanato Group is the second-largest maker of glass vials in the world, playing a crucial role in the distribution of vaccines, including those for COVID-19. Stevanato's career is marked by significant achievements, including being appointed a Cavaliere del Lavoro in 2007, an honor recognizing his contributions to industry and entrepreneurship. As of March 25, 2026, the Stevanato family has a net worth of $3.7 billion.

How to read Sergio Stevanato & family's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Sergio Stevanato & family, we anchor the narrative to Medical packaging and Medical packaging, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $4.305B alongside global rank #977, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (ITALY) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Sergio Stevanato was born on March 20, 1943, in Venice, Italy. He came from a family with a strong entrepreneurial background; his father, Giovanni Stevanato, founded Soffieria Stella, a glass manufacturing company, in 1949. Growing up, Sergio developed an interest in the glass industry, spending his summers working in the family business.

Rise to Success

After graduating with a law degree from the University of Ferrara in 1969, Sergio Stevanato took over the leadership of the Stevanato Group. Under his guidance, the company evolved from a producer of glass bottles for wine and perfume into a global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical and biotechnology industries. He spearheaded the expansion of the company, establishing a significant presence in the medical packaging sector, including becoming the second-largest producer of glass vials globally. The company's pivotal role in providing vials for COVID-19 vaccines further highlighted its impact.

Key Business Strategies

Stevanato's leadership emphasized technical excellence, quality, and global scale, achieved through strategic plant expansions in Italy, the U.S., Mexico, and Asia. The company focused on integrating its services, moving from basic vials to ready-to-use formats, cartridges, and pre-fillable syringes. This approach strengthened its position in the market, securing significant partnerships with major pharmaceutical companies. The company went public on the New York Stock Exchange (NYSE) in 2021, further solidifying its global presence.

Philanthropy

While specific amounts are not readily available, Sergio Stevanato is known for his passion for philanthropy and has supported various charitable causes and initiatives.

Career Timeline

2021

Stevanato Group IPO

Stevanato Group went public on the New York Stock Exchange

2007

Appointed Cavaliere del Lavoro

Sergio Stevanato was appointed Cavaliere del Lavoro (Knight of Labor) by the President of the Italian Republic

1969

Took over Leadership of Stevanato Group

Sergio Stevanato took over the leadership of Stevanato Group, the family business

1969

Graduated with Law Degree

Sergio Stevanato graduated with a law degree from the University of Ferrara

1949

Founded Soffieria Stella

Giovanni Stevanato founded a glass bottle manufacturing company in Venice, Italy, which later became Stevanato Group

Philanthropic Impact

PhilanthropyUndisclosed

Various Charitable Causes

Supports various charitable causes and initiatives

Key Business Ventures & Holdings

CompanyStakeValue
Stevanato Group53.00%$3.1M

Net Worth History

In-Depth Analysis

Early Life

Sergio Stevanato was born on March 20, 1943, in Venice, Italy. He came from a family with a strong entrepreneurial background; his father, Giovanni Stevanato, founded Soffieria Stella, a glass manufacturing company, in 1949. Growing up, Sergio developed an interest in the glass industry, spending his summers working in the family business.

Rise to Success

After graduating with a law degree from the University of Ferrara in 1969, Sergio Stevanato took over the leadership of the Stevanato Group. Under his guidance, the company evolved from a producer of glass bottles for wine and perfume into a global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical and biotechnology industries. He spearheaded the expansion of the company, establishing a significant presence in the medical packaging sector, including becoming the second-largest producer of glass vials globally. The company's pivotal role in providing vials for COVID-19 vaccines further highlighted its impact.

Key Business Strategies

Stevanato's leadership emphasized technical excellence, quality, and global scale, achieved through strategic plant expansions in Italy, the U.S., Mexico, and Asia. The company focused on integrating its services, moving from basic vials to ready-to-use formats, cartridges, and pre-fillable syringes. This approach strengthened its position in the market, securing significant partnerships with major pharmaceutical companies. The company went public on the New York Stock Exchange (NYSE) in 2021, further solidifying its global presence.

Philanthropy

While specific amounts are not readily available, Sergio Stevanato is known for his passion for philanthropy and has supported various charitable causes and initiatives.

Data Sources & Methodology

Figures for Sergio Stevanato & family are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.